Rhabdomyolysis following initiation of posaconazole use for antifungal prophylaxis in a patient with relapsed acute myeloid leukemia: A case report

Mayur D. Mody, Deepak Ravindranathan, Harpaul S. Gill, Vamsi K. Kota

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Posaconazole is a commonly used medication for antifungal prophylaxis in patients with high-risk acute leukemia, such as acute myeloid leukemia. Despite clinical data that show that posaconazole is superior to other antifungal prophylaxis medications, posaconazole is known to have many side effects and drug-drug interactions. We present a patient who developed rhabdomyolysis after being started on posaconazole for prophylaxis in the setting of relapsed acute myeloid leukemia.

Original languageEnglish (US)
JournalJournal of Investigative Medicine High Impact Case Reports
Volume5
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Drug interactions
prophylaxis
Rhabdomyolysis
Acute Myeloid Leukemia
medication
drug
Drug-Related Side Effects and Adverse Reactions
Drug Interactions
Leukemia
interaction
posaconazole

Keywords

  • AML
  • Acute myeloid leukemia
  • Posaconazole
  • Rhabdomyolysis

ASJC Scopus subject areas

  • Epidemiology
  • Safety, Risk, Reliability and Quality
  • Safety Research

Cite this

@article{cf6d1f7199c04482995e85fd39218b58,
title = "Rhabdomyolysis following initiation of posaconazole use for antifungal prophylaxis in a patient with relapsed acute myeloid leukemia: A case report",
abstract = "Posaconazole is a commonly used medication for antifungal prophylaxis in patients with high-risk acute leukemia, such as acute myeloid leukemia. Despite clinical data that show that posaconazole is superior to other antifungal prophylaxis medications, posaconazole is known to have many side effects and drug-drug interactions. We present a patient who developed rhabdomyolysis after being started on posaconazole for prophylaxis in the setting of relapsed acute myeloid leukemia.",
keywords = "AML, Acute myeloid leukemia, Posaconazole, Rhabdomyolysis",
author = "Mody, {Mayur D.} and Deepak Ravindranathan and Gill, {Harpaul S.} and Kota, {Vamsi K.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1177/2324709617690747",
language = "English (US)",
volume = "5",
journal = "Journal of Investigative Medicine High Impact Case Reports",
issn = "2324-7096",
publisher = "Sage Publications",
number = "1",

}

TY - JOUR

T1 - Rhabdomyolysis following initiation of posaconazole use for antifungal prophylaxis in a patient with relapsed acute myeloid leukemia

T2 - A case report

AU - Mody, Mayur D.

AU - Ravindranathan, Deepak

AU - Gill, Harpaul S.

AU - Kota, Vamsi K.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Posaconazole is a commonly used medication for antifungal prophylaxis in patients with high-risk acute leukemia, such as acute myeloid leukemia. Despite clinical data that show that posaconazole is superior to other antifungal prophylaxis medications, posaconazole is known to have many side effects and drug-drug interactions. We present a patient who developed rhabdomyolysis after being started on posaconazole for prophylaxis in the setting of relapsed acute myeloid leukemia.

AB - Posaconazole is a commonly used medication for antifungal prophylaxis in patients with high-risk acute leukemia, such as acute myeloid leukemia. Despite clinical data that show that posaconazole is superior to other antifungal prophylaxis medications, posaconazole is known to have many side effects and drug-drug interactions. We present a patient who developed rhabdomyolysis after being started on posaconazole for prophylaxis in the setting of relapsed acute myeloid leukemia.

KW - AML

KW - Acute myeloid leukemia

KW - Posaconazole

KW - Rhabdomyolysis

UR - http://www.scopus.com/inward/record.url?scp=85055661288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055661288&partnerID=8YFLogxK

U2 - 10.1177/2324709617690747

DO - 10.1177/2324709617690747

M3 - Article

AN - SCOPUS:85055661288

VL - 5

JO - Journal of Investigative Medicine High Impact Case Reports

JF - Journal of Investigative Medicine High Impact Case Reports

SN - 2324-7096

IS - 1

ER -